Navigenics Cuts Price of Screening Service 60 Percent
July 17, 2009
Navigenics Cuts Price of Screening Service 60 Percent
The firm cut the price of its comprehensive genetic screening service by 60 percent, following 23andMe's price drop last year.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- ACOG Committee Urges Caution for Genetic Testing to Assess Disease Risk
May 30, 2012 / Pharmacogenomics Reporter - PGen Study to Survey 1K Subjects to Investigate Impact of Personal Genomics Data
March 7, 2012 / Pharmacogenomics Reporter - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter - American Bar Association Passes Resolution on DTC Marketing of Genetic Tests
August 24, 2011 / Pharmacogenomics Reporter - DTC Genomics Firms Say They Want to Comply with FDA Regs but Maintain Direct Access
March 16, 2011 / Pharmacogenomics Reporter